MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Clinical trials for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE explained in plain language.
Never miss a new study
Get alerted when new MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE trials appear
Sign up with your email to follow new studies for MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Withdrawn trial sought to tame nerve pain from blood disorder
Disease control TerminatedThis study aimed to see if a medication called daratumumab could improve nerve damage symptoms in adults with MGUS, a blood condition that can harm nerves. Participants would have received injections weekly for two months, then every other week for four more months, while doctors…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Georgetown University • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Can eating plants stop cancer before it starts?
Prevention OngoingThis small pilot study is testing whether a 12-week whole food, plant-based diet is practical and helpful for overweight people with early blood cell conditions (MGUS or smoldering myeloma) that can sometimes turn into cancer. Researchers want to see if participants can stick to …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Prevention
Last updated Mar 30, 2026 14:33 UTC
-
Nationwide blood test hunt aims to stop cancer before it starts
Prevention OngoingThis study is testing whether screening a large population for a common, early blood condition (MGUS) can help prevent or better manage multiple myeloma, a type of blood cancer. Over 80,000 adults in Iceland are having their existing blood samples checked. Those found to have the…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: NA • Sponsor: University of Iceland • Aim: Prevention
Last updated Mar 24, 2026 12:02 UTC
-
Common diabetes pill tested to stop blood cancer before it starts
Prevention OngoingThis study is testing whether metformin, a common diabetes medication, can prevent people with early blood cell conditions (MGUS and smoldering myeloma) from developing full multiple myeloma, a type of blood cancer. About 60 participants will take either metformin or a placebo pi…
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Phase: PHASE2 • Sponsor: Dana-Farber Cancer Institute • Aim: Prevention
Last updated Mar 23, 2026 15:17 UTC
-
Mayo clinic launches major study to unlock genetic secrets of blood condition
Knowledge-focused ENROLLING_BY_INVITATIONThis study aims to screen adults for a blood condition called MGUS and learn more about the genetic and immune factors linked to it. Researchers will enroll 1,000 adults from diverse backgrounds in Minnesota to check for MGUS and collect blood samples and health information. The …
Matched conditions: MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE
Sponsor: Mayo Clinic • Aim: Knowledge-focused
Last updated Apr 02, 2026 14:56 UTC